| Kera Parker, OT | |
|
6800 Nw 39th Expy, Bethany, OK 73008-2513 | |
| (405) 440-9866 | |
| (405) 438-3834 |
| Full Name | Kera Parker |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 6800 Nw 39th Expy, Bethany, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649764044 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 5243 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kera Parker, OT 6800 Nw 39th Expy, Bethany, OK 73008-2513 Ph: (405) 440-9866 | Kera Parker, OT 6800 Nw 39th Expy, Bethany, OK 73008-2513 Ph: (405) 440-9866 |
News Archive
Cannabis Science, Inc., a pioneering U.S. biotech company developing pharmaceutical cannabis products, is pleased to report that Montana Governor Brian Schweitzer visited its latest acquisition, Montana Pain Management in Missoula, yesterday. Governor Schweitzer observed, "You are doing it right."
At the joint conference of the American Society of Human Genetics/International Congress on Human Genetics in Montreal on October 12, GeneDx, one of the foremost genetics laboratories in the world and a subsidiary of Bio-Reference Laboratories, Inc., is announcing a first-of-its-kind test that will enable physicians and patients to more accurately identify the genetic cause of rare diseases.
In a huge victory for ALS sufferers, FDA granted Genervon Biopharmaceuticals a fast track designation for its first in class highly effective multi-target master regulator biotechnology drug GM604 for ALS. FDA said it met the necessary criteria.
Researchers of the University of Granada have demonstrated that patients who have damage to the right prefrontal cortex of the brain -the part involved in anticipation and quick reaction to stimuli- present a deficit in intentional anticipation (for example, when we put the vehicle in gear before the light turns green). However, these patients keep unintentional anticipation functions intact, which could help develop new therapies.
A team of researchers from the National University of Singapore (NUS) has utilized a ground-breaking artificial intelligence (AI) platform to derive an optimal combination of available therapies against SARS-CoV-2, the cause of COVID-19.
› Verified 6 days ago
Kevin Robert Johnson, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-789-6711 Fax: 405-440-6711 | |
Rachel George, MOT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-789-6711 Fax: 405-440-6750 | |
Michelle Lynn Sherman, MOT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-789-6711 Fax: 405-440-6750 | |
Andrea Williams, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-440-9866 Fax: 405-782-0024 | |
Jana Campos, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-789-6711 | |
Morgan Mowdy, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-789-6711 Fax: 405-438-3834 | |
Nicole Reine, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-470-2326 |